US 7,547,682 B2
Tick galectin
Kozo Fujisaki, c/o Obihiro University of Agriculture and Veterinary Medicine National Research Center for Protozoan Diseases, 13 Nishinisen, Inada-cho, Obihiro-shi, Hokkaido 080-8555 (Japan); Hideyuki Nagasawa, Hokkaido (Japan); Ikuo Igarashi, Hokkaido (Japan); Hiroshi Suzuki, Hokkaido (Japan); Chihiro Sugimoto, Hokkaido (Japan); Gakunan Gen, Hokkaido (Japan); Kimie Kadota, Hokkaido (Japan); Noboru Inoue, Hokkaido (Japan); Naoaki Yokoyama, Hokkaido (Japan); and Naotoshi Tsuji, Ibaraki (Japan)
Assigned to Meiji Seika Kaisha, Ltd., Tokyo (Japan); and Kozo Fujisaki, Hokkaido (Japan)
Filed on Sep. 22, 2006, as Appl. No. 11/525,044.
Application 11/525044 is a continuation of application No. 10/506047, granted, now 7,135,552, previously published as PCT/JP03/02336, filed on Feb. 28, 2003.
Claims priority of application No. 2002-53146 (JP), filed on Feb. 28, 2002.
Prior Publication US 2007/0021596 A1, Jan. 25, 2007
This patent is subject to a terminal disclaimer.
Int. Cl. A61K 31/70 (2006.01); A61K 48/00 (2006.01); C07H 21/02 (2006.01); C07H 21/04 (2006.01)
U.S. Cl. 514—44  [536/23.1; 424/93.1] 4 Claims
 
1. A method for generating an immune response in a subject, comprising administering:
(i) a polynucleotide encoding a polypeptide comprising the amino acid sequence of SEQ ID NO: 2; or
(ii) an expression vector comprising the polynucleotide.